Jiangsu Hengrui Medicine Statistics
Total Valuation
HKG:1276 has a market cap or net worth of HKD 521.08 billion. The enterprise value is 482.20 billion.
Market Cap | 521.08B |
Enterprise Value | 482.20B |
Important Dates
The next estimated earnings date is Monday, October 27, 2025.
Earnings Date | Oct 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 258.20M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.62% |
Shares Change (QoQ) | +3.54% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.68B |
Valuation Ratios
The trailing PE ratio is 64.66 and the forward PE ratio is 50.23.
PE Ratio | 64.66 |
Forward PE | 50.23 |
PS Ratio | 15.77 |
PB Ratio | 8.06 |
P/TBV Ratio | 8.33 |
P/FCF Ratio | 74.09 |
P/OCF Ratio | 54.72 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 53.02, with an EV/FCF ratio of 68.56.
EV / Earnings | 59.83 |
EV / Sales | 14.64 |
EV / EBITDA | 53.02 |
EV / EBIT | 58.75 |
EV / FCF | 68.56 |
Financial Position
The company has a current ratio of 13.49, with a Debt / Equity ratio of 0.00.
Current Ratio | 13.49 |
Quick Ratio | 12.21 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | 0.01 |
Interest Coverage | 539.99 |
Financial Efficiency
Return on equity (ROE) is 14.41% and return on invested capital (ROIC) is 9.15%.
Return on Equity (ROE) | 14.41% |
Return on Assets (ROA) | 8.45% |
Return on Invested Capital (ROIC) | 9.15% |
Return on Capital Employed (ROCE) | 12.64% |
Revenue Per Employee | 1.63M |
Profits Per Employee | 398,228 |
Employee Count | 20,238 |
Asset Turnover | 0.54 |
Inventory Turnover | 1.72 |
Taxes
In the past 12 months, HKG:1276 has paid 1.21 billion in taxes.
Income Tax | 1.21B |
Effective Tax Rate | 13.05% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 81.14 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 57.60 |
Average Volume (20 Days) | 5,338,377 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1276 had revenue of HKD 33.03 billion and earned 8.06 billion in profits. Earnings per share was 1.27.
Revenue | 33.03B |
Gross Profit | 28.49B |
Operating Income | 8.23B |
Pretax Income | 9.28B |
Net Income | 8.06B |
EBITDA | 9.08B |
EBIT | 8.23B |
Earnings Per Share (EPS) | 1.27 |
Balance Sheet
The company has 39.70 billion in cash and 100.19 million in debt, giving a net cash position of 39.60 billion.
Cash & Cash Equivalents | 39.70B |
Total Debt | 100.19M |
Net Cash | 39.60B |
Net Cash Per Share | n/a |
Equity (Book Value) | 64.68B |
Book Value Per Share | 9.91 |
Working Capital | 47.44B |
Cash Flow
In the last 12 months, operating cash flow was 9.52 billion and capital expenditures -2.49 billion, giving a free cash flow of 7.03 billion.
Operating Cash Flow | 9.52B |
Capital Expenditures | -2.49B |
Free Cash Flow | 7.03B |
FCF Per Share | n/a |
Margins
Gross margin is 86.24%, with operating and profit margins of 24.91% and 24.40%.
Gross Margin | 86.24% |
Operating Margin | 24.91% |
Pretax Margin | 28.09% |
Profit Margin | 24.40% |
EBITDA Margin | 27.48% |
EBIT Margin | 24.91% |
FCF Margin | 21.29% |
Dividends & Yields
HKG:1276 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 34.66% |
Buyback Yield | -0.62% |
Shareholder Yield | n/a |
Earnings Yield | 1.55% |
FCF Yield | 1.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:1276 has an Altman Z-Score of 49.39 and a Piotroski F-Score of 6.
Altman Z-Score | 49.39 |
Piotroski F-Score | 6 |